Blog - Page 3914 of 5592

FridayNov 20, 2009 2:31 pm

Omnicity Corp.’s (OMCY.OB) Recently-Issued Corporate Update

Omnicity Corp. provides broadband access – including advanced voice, video and data services – to under-served and un-served small and rural markets. The company is the Midwest's largest and fastest growing fixed wireless internet service provider. The company issued a corporate update summarizing the status of Omnicity's business growth plan for fiscal year 2010 several weeks ago. The company stated they will continue to partner with rural electric membership cooperatives (REMCs) and rural telecom companies along with state and local governments in order to expand their network across rural America. Omnicity also pledged to expand their service offerings and become…

FridayNov 20, 2009 2:28 pm

Soligenix Inc. (SNGX.OB) Taking Steps to Meet Challenges of Vaccine Technology and Biological Warfare

Soligenix Inc., formerly known as DOR BioPharma Inc., a late-stage biotechnology company, today announced it has formed a consortium to develop technology to enhance acting vaccines, including RiVax, the company’s proprietary vaccine for ricin toxin, which can be used as a biological weapon. Soligenix also announced it was awarded a $9.4 million grant from the National Institute of Allergy and Infectious Diseases (NIAID), a division of the National Institutes of Health (NIH), to continue this work. The announced consortium draws together industry and academic researchers from various disciplines, including the University of Colorado, the University of Kansas, and the Tulane…

FridayNov 20, 2009 2:26 pm

Genta Inc. (GETA.OB) Cancer Drug Shown Effective with Chemotherapy in Advanced Melanoma

Genta Inc. released the results from a pilot study on advanced melanoma incorporating the Company’s cancer drug Genasense(R) (oblimersen sodium). This study was featured earlier this week in a presentation at the World Meeting of Interdisciplinary Melanoma/Skin Cancer Centers in Berlin, Germany, an international conference organized every year by a co-leader of the AGENDA trial, the European Association of Dermatologic Oncology (EADO). Genasense, delivered for the first time in a high-dose, 1-hour intravenous (IV) format, was used along with the most common melanoma drug temozolomide (Temodar(R); Schering Plough, Inc.), and a paclitaxel suspension (Abraxane(R); Abraxis Bioscience, Inc.). Using a standard…

FridayNov 20, 2009 2:23 pm

Biotel Inc. (BTEL) Reports Profitable Quarter

Biotel Inc. (BTEL) reported net income of $128,000, or $0.04 per diluted share, for the third quarter of 2009. This was down from the $328,000, or $0.11 per diluted share, reported a year earlier. Revenues in the quarter were reported at $3.2 million, up 3% from the $3.1 million reported in the third quarter of 2008. Steve Springrose, the CEO of Biotel Inc., said, “Biotel enjoyed strong sales and earnings through the first quarter and believes its upcoming new wireless event and MCT products have favorable attributes for the arrhythmia service market.” In April 2009, Biotel Inc. announced a merger…

FridayNov 20, 2009 2:22 pm

China Forestry, Inc. (CHFY.OB) Signs Letter of Intent to Acquire Gaoxin Agriculture

Timber investment group China Forestry Inc. announced today that the company has signed a letter of intent to acquire the landscape engineering and construction firm Shaan'Xi Province Gaoxin Agriculture and Animal Husbandry Development Holding Co., Ltd. The company, located in Xi'An City, Shaan'Xi Province, generated over RMB 81 million in revenue in 2008. China Forestry feels that acquiring Goaxin will bring a weighty advantage in pursuing its mission to capitalize on the Chinese Government's decision to promote sustainable forest management through land tenure. Goaxin provides landscape design, engineering, construction and maintenance services to a target market of universities, parks, municipal…

FridayNov 20, 2009 2:21 pm

International Stem Cell Corporation (ISCO.OB) to Collaborate with Scripps Research Institute in Stem Cell Research

Today, International Stem Cell Corporation announced that it will collaborate with renowned stem cell researcher Jeanne F. Loring, Ph.D. and the Scripps Research Institute (located in La Jolla, CA) to study parthenogenetic stem cells and their potentially derived therapeutic cells. The study expands the company’s mission to generate data necessary to understand these cells and move them closer to the clinic. ISCO has perfected a process using unfertilized human eggs to creating human stem cells. These “parthenogenetic” stem cells allow immune-matching to large segments of the population. ISCO’s process allows the company to avoid the ethical debate regarding the use…

FridayNov 20, 2009 1:44 pm

Muscle Flex, Inc. (MFLI.PK) Invites Public to Tune into MuscleFlexInc.com for the American Music Awards Online Pre-Show

Muscle Flex Inc. today invited the public to tune into www.MuscleFlexInc.com for the American Music Awards Online Pre-Show Sunday, November 22, 2009 from 3:00 - 5:00 PM broadcast live from the Red Carpet at the Nokia Theatre with Muscle Flex CEO Danny Alex as the Official Fitness and Lifestyle Expert Commentator. Danny Alex will participate live on the American Music Awards online pre-show with Muscle Flex brands being referenced during his segments which will focus on fitness and lifestyle. The AMAs will broadcast live from the Nokia Theatre LA LIVE on Sunday, November 22 (8-11 p.m. EASTERN and PACIFIC) on…

FridayNov 20, 2009 12:00 pm

Small Cap Voice Featured Company: Rival Technologies Inc. (RVTI.OB)

Rival Technologies Inc. is an innovative energy related technology company focused on investing in emerging technologies that display extraordinary market potential. The company has filed several provisional patents and patent applications and is focused on licensing its technology for industry use. Rival Technologies. Inc. is the parent company of TRU Oiltech Inc. which researches alternative systems and heavy oil upgrading technology to enhance the process of moving oil sands bitumen to processing plants. The subsidiary is expected to provide substantial per barrel cost savings over existing methods. The company is currently transitioning the TRU process technology from the lab to…

FridayNov 20, 2009 11:54 am

Small Cap Voice Featured Company: Xcellink International Inc. (XCEL.OB)

Xcellink International Inc. is focused on developing advanced platform-independent customer-centric payment systems and methodologies. The company’s patented system has the ability to replace all credit, debit, charge and smart cards, providing all functions of order, warehousing, delivery and payment for all types of goods and services. Xcellink has the potential to become a major player in the next generation of customer payment systems. The company’s unique process enables customers, rather than the merchant, to initiate, control and pay for all transactions, without the need for credit cards, in real-time anywhere, anytime, and at a fraction of the cost of current…

FridayNov 20, 2009 11:24 am

OPTIMIZERx Corp. (OPRX.OB) Retains Services of Beringea LLC for Growth Advice

OPTIMIZERx Corp. announced that it has engaged Beringea LLC, an investment banking and private equity firm. Beringea will assist in financial planning and strategically positioning the company for continued growth. "Beringea specializes in advising clients who are seeking to execute strategic transactions or find private financing," stated David Lester, CEO, OPRIMIZERx. "As we continue to position OPTIMIZERx's growth within the healthcare marketplace we look to Beringea to be a strategic advisory partner for both growth and financial stability." "Beringea's transaction advisory team has a deep expertise in the healthcare sector and is excited to share OPTIMIZERx's value proposition with the…

Site Search

Company Search